Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

26-09-2019

Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014–2017 BRFSS

Auteurs: Billy A. Caceres, Kasey B. Jackman, Donald Edmondson, Walter O. Bockting

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 2/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

The purpose of this study was to assess gender identity differences in CVD risk and CVD conditions among adults in the U.S. Using data from the 2014–2017 BRFSS we compared CVD risk and CVD conditions in gender minorities (transgender men, transgender women and gender nonconforming persons) to both cisgender men and women. The sample consisted of 662,903 participants. Transgender women (AOR 1.34, 95% CI 1.05–1.72) and transgender men (AOR 1.54, 95% CI 1.07–2.24) were more likely to be overweight than cisgender women. Compared to cisgender women, transgender women reported higher rates of diabetes (AOR 1.45, 95% CI 1.05–1.99), angina/coronary heart disease (AOR 1.90, 95% CI 1.34–2.68), stroke (AOR 1.88, 95% CI 1.16–3.03), and myocardial infarction (AOR 2.98, 95% CI 2.14–4.17). Gender nonconforming participants (AOR 2.68, 95% CI 1.14–6.30) reported higher odds of myocardial infarction than cisgender women. Transgender women also had higher rates of reporting any CVD than cisgender men (AOR 1.38, 95% CI 1.01–1.88). There is a need to elucidate the cardiovascular effects of minority stressors and gender affirming therapy in this population. More research focused on CVD prevention and management in gender minorities is recommended.
Literatuur
go back to reference Gamarel, K. E., Mereish, E. H., Manning, D., Iwamoto, M., Operario, D., & Nemoto, T. (2016). Minority stress, smoking patterns, and cessation attempts: Findings from a community-sample of transgender women in the San Francisco Bay area. Nicotine & Tobacco Research,18, 306–313. https://doi.org/10.1093/ntr/ntv066 CrossRef Gamarel, K. E., Mereish, E. H., Manning, D., Iwamoto, M., Operario, D., & Nemoto, T. (2016). Minority stress, smoking patterns, and cessation attempts: Findings from a community-sample of transgender women in the San Francisco Bay area. Nicotine & Tobacco Research,18, 306–313. https://​doi.​org/​10.​1093/​ntr/​ntv066 CrossRef
go back to reference Institute of Medicine. (2011). The health of lesbian, gay, bisexual, and transgender people: Building a foundation for better understanding. Washington, DC: National Academies Press. Institute of Medicine. (2011). The health of lesbian, gay, bisexual, and transgender people: Building a foundation for better understanding. Washington, DC: National Academies Press.
go back to reference Maraka, S., Singh Ospina, N., Rodriguez-Gutierrez, R., Davidge-Pitts, C. J., Nippoldt, T. B., Prokop, L. J., et al. (2017). Sex steroids and cardiovascular outcomes in transgender Individuals: A systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism,102, 3914–3923. https://doi.org/10.1210/jc.2017-01643 CrossRefPubMed Maraka, S., Singh Ospina, N., Rodriguez-Gutierrez, R., Davidge-Pitts, C. J., Nippoldt, T. B., Prokop, L. J., et al. (2017). Sex steroids and cardiovascular outcomes in transgender Individuals: A systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism,102, 3914–3923. https://​doi.​org/​10.​1210/​jc.​2017-01643 CrossRefPubMed
go back to reference Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., et al. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: A case–control study. European Journal of Endocrinology,169, 471–478. https://doi.org/10.1530/EJE-13-0493 CrossRefPubMed Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., et al. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: A case–control study. European Journal of Endocrinology,169, 471–478. https://​doi.​org/​10.​1530/​EJE-13-0493 CrossRefPubMed
Metagegevens
Titel
Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014–2017 BRFSS
Auteurs
Billy A. Caceres
Kasey B. Jackman
Donald Edmondson
Walter O. Bockting
Publicatiedatum
26-09-2019
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 2/2020
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-019-00102-8